source name	characteristics[organism]	characteristics[organism part]	characteristics[cell type]	characteristics[ancestry category]	characteristics[age]	characteristics[sex]	characteristics[disease]	characteristics[biological replicate]	Material Type	technology type	assay name	comment[technical replicate]	comment[data file]	comment[file uri]	comment[fraction identifier]	comment[label]	comment[instrument]	comment[cleavage agent details]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[dissociation method]	comment[collision energy]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	factor value[disease]
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 1	1	w001.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w001.raw	1	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 1	1	w001.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w001.raw	1	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 1	1	w001.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w001.raw	1	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 1	1	w001.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w001.raw	1	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 1	1	w001.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w001.raw	1	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 1	1	w001.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w001.raw	1	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 1	1	w001.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w001.raw	1	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 1	1	w001.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w001.raw	1	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 1	1	w001.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w001.raw	1	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 1	1	w001.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w001.raw	1	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 2	1	w002.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w002.raw	2	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 2	1	w002.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w002.raw	2	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 2	1	w002.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w002.raw	2	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 2	1	w002.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w002.raw	2	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 2	1	w002.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w002.raw	2	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 2	1	w002.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w002.raw	2	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 2	1	w002.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w002.raw	2	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 2	1	w002.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w002.raw	2	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 2	1	w002.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w002.raw	2	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 2	1	w002.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w002.raw	2	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 3	1	w003.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w003.raw	3	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 3	1	w003.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w003.raw	3	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 3	1	w003.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w003.raw	3	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 3	1	w003.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w003.raw	3	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 3	1	w003.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w003.raw	3	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 3	1	w003.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w003.raw	3	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 3	1	w003.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w003.raw	3	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 3	1	w003.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w003.raw	3	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 3	1	w003.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w003.raw	3	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 3	1	w003.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w003.raw	3	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 4	1	w004.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w004.raw	4	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 4	1	w004.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w004.raw	4	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 4	1	w004.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w004.raw	4	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 4	1	w004.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w004.raw	4	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 4	1	w004.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w004.raw	4	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 4	1	w004.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w004.raw	4	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 4	1	w004.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w004.raw	4	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 4	1	w004.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w004.raw	4	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 4	1	w004.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w004.raw	4	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 4	1	w004.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w004.raw	4	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 5	1	w005.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w005.raw	5	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 5	1	w005.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w005.raw	5	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 5	1	w005.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w005.raw	5	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 5	1	w005.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w005.raw	5	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 5	1	w005.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w005.raw	5	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 5	1	w005.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w005.raw	5	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 5	1	w005.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w005.raw	5	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 5	1	w005.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w005.raw	5	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 5	1	w005.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w005.raw	5	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 5	1	w005.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w005.raw	5	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 6	1	w006.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w006.raw	6	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 6	1	w006.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w006.raw	6	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 6	1	w006.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w006.raw	6	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 6	1	w006.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w006.raw	6	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 6	1	w006.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w006.raw	6	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 6	1	w006.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w006.raw	6	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 6	1	w006.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w006.raw	6	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 6	1	w006.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w006.raw	6	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 6	1	w006.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w006.raw	6	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 6	1	w006.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w006.raw	6	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 7	1	w007.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w007.raw	7	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 7	1	w007.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w007.raw	7	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 7	1	w007.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w007.raw	7	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 7	1	w007.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w007.raw	7	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 7	1	w007.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w007.raw	7	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 7	1	w007.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w007.raw	7	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 7	1	w007.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w007.raw	7	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 7	1	w007.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w007.raw	7	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 7	1	w007.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w007.raw	7	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 7	1	w007.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w007.raw	7	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 8	1	w008.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w008.raw	8	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 8	1	w008.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w008.raw	8	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 8	1	w008.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w008.raw	8	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 8	1	w008.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w008.raw	8	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 8	1	w008.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w008.raw	8	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 8	1	w008.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w008.raw	8	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 8	1	w008.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w008.raw	8	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 8	1	w008.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w008.raw	8	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 8	1	w008.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w008.raw	8	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 8	1	w008.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w008.raw	8	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 9	1	/w09.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w09.raw	9	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 9	1	/w09.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w09.raw	9	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 9	1	/w09.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w09.raw	9	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 9	1	/w09.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w09.raw	9	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 9	1	/w09.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w09.raw	9	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 9	1	/w09.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w09.raw	9	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 9	1	/w09.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w09.raw	9	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 9	1	/w09.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w09.raw	9	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 9	1	/w09.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w09.raw	9	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 9	1	/w09.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w09.raw	9	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 10	1	w010.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w010.raw	10	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 10	1	w010.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w010.raw	10	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 10	1	w010.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w010.raw	10	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 10	1	w010.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w010.raw	10	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 10	1	w010.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w010.raw	10	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 10	1	w010.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w010.raw	10	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 10	1	w010.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w010.raw	10	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 10	1	w010.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w010.raw	10	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 10	1	w010.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w010.raw	10	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 10	1	w010.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w010.raw	10	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 11	1	w011.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w011.raw	11	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 11	1	w011.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w011.raw	11	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 11	1	w011.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w011.raw	11	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 11	1	w011.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w011.raw	11	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 11	1	w011.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w011.raw	11	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 11	1	w011.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w011.raw	11	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 11	1	w011.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w011.raw	11	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 11	1	w011.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w011.raw	11	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 11	1	w011.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w011.raw	11	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 11	1	w011.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w011.raw	11	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 12	1	w012.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w012.raw	12	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 12	1	w012.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w012.raw	12	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 12	1	w012.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w012.raw	12	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 12	1	w012.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w012.raw	12	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 12	1	w012.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w012.raw	12	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 12	1	w012.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w012.raw	12	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 12	1	w012.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w012.raw	12	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 12	1	w012.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w012.raw	12	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 12	1	w012.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w012.raw	12	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 12	1	w012.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w012.raw	12	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 13	1	w013.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w013.raw	13	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 13	1	w013.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w013.raw	13	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 13	1	w013.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w013.raw	13	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 13	1	w013.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w013.raw	13	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 13	1	w013.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w013.raw	13	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 13	1	w013.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w013.raw	13	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 13	1	w013.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w013.raw	13	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 13	1	w013.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w013.raw	13	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 13	1	w013.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w013.raw	13	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 13	1	w013.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w013.raw	13	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 14	1	w014.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w014.raw	14	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 14	1	w014.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w014.raw	14	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 14	1	w014.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w014.raw	14	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 14	1	w014.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w014.raw	14	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 14	1	w014.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w014.raw	14	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 14	1	w014.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w014.raw	14	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 14	1	w014.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w014.raw	14	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 14	1	w014.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w014.raw	14	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 14	1	w014.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w014.raw	14	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 14	1	w014.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w014.raw	14	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 15	1	w015.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w015.raw	15	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 15	1	w015.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w015.raw	15	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 15	1	w015.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w015.raw	15	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 15	1	w015.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w015.raw	15	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 15	1	w015.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w015.raw	15	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 15	1	w015.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w015.raw	15	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 15	1	w015.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w015.raw	15	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 15	1	w015.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w015.raw	15	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 15	1	w015.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w015.raw	15	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 15	1	w015.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w015.raw	15	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 16	1	w016.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w016.raw	16	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 16	1	w016.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w016.raw	16	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 16	1	w016.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w016.raw	16	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 16	1	w016.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w016.raw	16	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 16	1	w016.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w016.raw	16	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 16	1	w016.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w016.raw	16	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 16	1	w016.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w016.raw	16	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 16	1	w016.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w016.raw	16	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 16	1	w016.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w016.raw	16	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 16	1	w016.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w016.raw	16	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 17	1	w017.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w017.raw	17	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 17	1	w017.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w017.raw	17	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 17	1	w017.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w017.raw	17	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 17	1	w017.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w017.raw	17	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 17	1	w017.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w017.raw	17	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 17	1	w017.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w017.raw	17	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 17	1	w017.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w017.raw	17	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 17	1	w017.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w017.raw	17	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 17	1	w017.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w017.raw	17	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 17	1	w017.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w017.raw	17	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 18	1	w018.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w018.raw	18	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 18	1	w018.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w018.raw	18	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 18	1	w018.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w018.raw	18	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 18	1	w018.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w018.raw	18	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 18	1	w018.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w018.raw	18	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 18	1	w018.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w018.raw	18	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 18	1	w018.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w018.raw	18	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 18	1	w018.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w018.raw	18	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 18	1	w018.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w018.raw	18	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 18	1	w018.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w018.raw	18	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 19	1	w019.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w019.raw	19	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 19	1	w019.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w019.raw	19	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 19	1	w019.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w019.raw	19	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 19	1	w019.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w019.raw	19	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 19	1	w019.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w019.raw	19	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 19	1	w019.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w019.raw	19	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 19	1	w019.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w019.raw	19	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 19	1	w019.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w019.raw	19	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 19	1	w019.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w019.raw	19	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 19	1	w019.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w019.raw	19	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 20	1	w020.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w020.raw	20	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 20	1	w020.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w020.raw	20	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 20	1	w020.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w020.raw	20	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 20	1	w020.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w020.raw	20	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 20	1	w020.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w020.raw	20	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 20	1	w020.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w020.raw	20	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 20	1	w020.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w020.raw	20	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 20	1	w020.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w020.raw	20	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 20	1	w020.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w020.raw	20	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 20	1	w020.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w020.raw	20	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 21	1	w021.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w021.raw	21	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 21	1	w021.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w021.raw	21	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 21	1	w021.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w021.raw	21	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 21	1	w021.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w021.raw	21	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 21	1	w021.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w021.raw	21	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 21	1	w021.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w021.raw	21	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 21	1	w021.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w021.raw	21	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 21	1	w021.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w021.raw	21	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 21	1	w021.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w021.raw	21	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 21	1	w021.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w021.raw	21	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 22	1	w022.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w022.raw	22	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 22	1	w022.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w022.raw	22	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 22	1	w022.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w022.raw	22	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 22	1	w022.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w022.raw	22	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 22	1	w022.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w022.raw	22	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 22	1	w022.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w022.raw	22	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 22	1	w022.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w022.raw	22	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 22	1	w022.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w022.raw	22	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 22	1	w022.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w022.raw	22	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 22	1	w022.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w022.raw	22	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 23	1	w023.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w023.raw	23	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 23	1	w023.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w023.raw	23	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 23	1	w023.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w023.raw	23	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 23	1	w023.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w023.raw	23	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 23	1	w023.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w023.raw	23	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 23	1	w023.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w023.raw	23	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 23	1	w023.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w023.raw	23	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 23	1	w023.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w023.raw	23	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 23	1	w023.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w023.raw	23	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 23	1	w023.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w023.raw	23	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 24	1	w024.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w024.raw	24	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 24	1	w024.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w024.raw	24	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 24	1	w024.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w024.raw	24	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 24	1	w024.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w024.raw	24	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 24	1	w024.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w024.raw	24	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 24	1	w024.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w024.raw	24	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 24	1	w024.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w024.raw	24	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 24	1	w024.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w024.raw	24	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 24	1	w024.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w024.raw	24	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 24	1	w024.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w024.raw	24	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 25	1	w025.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w025.raw	25	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 25	1	w025.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w025.raw	25	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 25	1	w025.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w025.raw	25	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 25	1	w025.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w025.raw	25	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 25	1	w025.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w025.raw	25	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 25	1	w025.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w025.raw	25	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 25	1	w025.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w025.raw	25	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 25	1	w025.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w025.raw	25	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 25	1	w025.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w025.raw	25	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 25	1	w025.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w025.raw	25	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 26	1	w026.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w026.raw	26	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 26	1	w026.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w026.raw	26	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 26	1	w026.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w026.raw	26	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 26	1	w026.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w026.raw	26	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 26	1	w026.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w026.raw	26	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 26	1	w026.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w026.raw	26	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 26	1	w026.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w026.raw	26	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 26	1	w026.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w026.raw	26	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 26	1	w026.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w026.raw	26	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 26	1	w026.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w026.raw	26	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 27	1	w027.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w027.raw	27	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 27	1	w027.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w027.raw	27	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 27	1	w027.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w027.raw	27	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 27	1	w027.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w027.raw	27	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 27	1	w027.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w027.raw	27	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 27	1	w027.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w027.raw	27	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 27	1	w027.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w027.raw	27	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 27	1	w027.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w027.raw	27	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 27	1	w027.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w027.raw	27	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 27	1	w027.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w027.raw	27	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 28	1	w028.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w028.raw	28	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 28	1	w028.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w028.raw	28	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 28	1	w028.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w028.raw	28	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 28	1	w028.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w028.raw	28	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 28	1	w028.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w028.raw	28	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 28	1	w028.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w028.raw	28	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 28	1	w028.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w028.raw	28	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 28	1	w028.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w028.raw	28	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 28	1	w028.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w028.raw	28	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 28	1	w028.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w028.raw	28	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 29	1	w029.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w029.raw	29	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 29	1	w029.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w029.raw	29	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 29	1	w029.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w029.raw	29	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 29	1	w029.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w029.raw	29	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 29	1	w029.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w029.raw	29	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 29	1	w029.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w029.raw	29	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 29	1	w029.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w029.raw	29	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 29	1	w029.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w029.raw	29	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 29	1	w029.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w029.raw	29	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 29	1	w029.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w029.raw	29	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 30	1	w030.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w030.raw	30	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 30	1	w030.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w030.raw	30	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 30	1	w030.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w030.raw	30	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 30	1	w030.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w030.raw	30	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 30	1	w030.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w030.raw	30	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 30	1	w030.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w030.raw	30	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 30	1	w030.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w030.raw	30	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 30	1	w030.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w030.raw	30	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 30	1	w030.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w030.raw	30	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 30	1	w030.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w030.raw	30	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 31	1	w031.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w031.raw	31	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 31	1	w031.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w031.raw	31	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 31	1	w031.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w031.raw	31	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 31	1	w031.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w031.raw	31	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 31	1	w031.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w031.raw	31	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 31	1	w031.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w031.raw	31	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 31	1	w031.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w031.raw	31	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 31	1	w031.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w031.raw	31	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 31	1	w031.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w031.raw	31	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 31	1	w031.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w031.raw	31	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 32	1	w032.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w032.raw	32	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 32	1	w032.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w032.raw	32	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 32	1	w032.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w032.raw	32	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 32	1	w032.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w032.raw	32	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 32	1	w032.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w032.raw	32	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 32	1	w032.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w032.raw	32	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 32	1	w032.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w032.raw	32	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 32	1	w032.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w032.raw	32	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 32	1	w032.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w032.raw	32	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 32	1	w032.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w032.raw	32	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 33	1	w033.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w033.raw	33	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 33	1	w033.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w033.raw	33	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 33	1	w033.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w033.raw	33	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 33	1	w033.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w033.raw	33	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 33	1	w033.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w033.raw	33	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 33	1	w033.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w033.raw	33	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 33	1	w033.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w033.raw	33	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 33	1	w033.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w033.raw	33	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 33	1	w033.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w033.raw	33	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 33	1	w033.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w033.raw	33	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 34	1	w034.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w034.raw	34	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 34	1	w034.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w034.raw	34	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 34	1	w034.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w034.raw	34	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 34	1	w034.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w034.raw	34	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 34	1	w034.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w034.raw	34	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 34	1	w034.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w034.raw	34	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 34	1	w034.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w034.raw	34	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 34	1	w034.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w034.raw	34	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 34	1	w034.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w034.raw	34	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 34	1	w034.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w034.raw	34	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 35	1	w035.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w035.raw	35	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 35	1	w035.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w035.raw	35	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 35	1	w035.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w035.raw	35	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 35	1	w035.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w035.raw	35	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 35	1	w035.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w035.raw	35	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 35	1	w035.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w035.raw	35	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 35	1	w035.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w035.raw	35	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 35	1	w035.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w035.raw	35	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 35	1	w035.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w035.raw	35	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 35	1	w035.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w035.raw	35	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 36	1	w036.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w036.raw	36	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 36	1	w036.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w036.raw	36	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 36	1	w036.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w036.raw	36	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 36	1	w036.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w036.raw	36	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 36	1	w036.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w036.raw	36	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 36	1	w036.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w036.raw	36	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 36	1	w036.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w036.raw	36	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 36	1	w036.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w036.raw	36	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 36	1	w036.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w036.raw	36	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 36	1	w036.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w036.raw	36	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 37	1	w037.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w037.raw	37	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 37	1	w037.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w037.raw	37	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 37	1	w037.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w037.raw	37	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 37	1	w037.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w037.raw	37	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 37	1	w037.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w037.raw	37	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 37	1	w037.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w037.raw	37	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 37	1	w037.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w037.raw	37	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 37	1	w037.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w037.raw	37	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 37	1	w037.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w037.raw	37	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 37	1	w037.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w037.raw	37	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 38	1	w038.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w038.raw	38	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 38	1	w038.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w038.raw	38	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 38	1	w038.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w038.raw	38	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 38	1	w038.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w038.raw	38	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 38	1	w038.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w038.raw	38	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 38	1	w038.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w038.raw	38	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 38	1	w038.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w038.raw	38	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 38	1	w038.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w038.raw	38	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 38	1	w038.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w038.raw	38	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 38	1	w038.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w038.raw	38	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 39	1	w039.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w039.raw	39	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 39	1	w039.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w039.raw	39	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 39	1	w039.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w039.raw	39	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 39	1	w039.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w039.raw	39	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 39	1	w039.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w039.raw	39	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 39	1	w039.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w039.raw	39	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 39	1	w039.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w039.raw	39	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 39	1	w039.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w039.raw	39	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 39	1	w039.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w039.raw	39	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 39	1	w039.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w039.raw	39	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 40	1	w040.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w040.raw	40	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 40	1	w040.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w040.raw	40	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 40	1	w040.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w040.raw	40	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 40	1	w040.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w040.raw	40	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 40	1	w040.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w040.raw	40	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 40	1	w040.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w040.raw	40	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 40	1	w040.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w040.raw	40	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 40	1	w040.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w040.raw	40	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 40	1	w040.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w040.raw	40	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 40	1	w040.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w040.raw	40	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 41	1	w041.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w041.raw	41	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 41	1	w041.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w041.raw	41	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 41	1	w041.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w041.raw	41	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 41	1	w041.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w041.raw	41	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 41	1	w041.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w041.raw	41	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 41	1	w041.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w041.raw	41	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 41	1	w041.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w041.raw	41	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 41	1	w041.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w041.raw	41	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 41	1	w041.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w041.raw	41	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 41	1	w041.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w041.raw	41	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 42	1	w042.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w042.raw	42	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 42	1	w042.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w042.raw	42	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 42	1	w042.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w042.raw	42	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 42	1	w042.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w042.raw	42	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 42	1	w042.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w042.raw	42	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 42	1	w042.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w042.raw	42	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 42	1	w042.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w042.raw	42	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 42	1	w042.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w042.raw	42	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 42	1	w042.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w042.raw	42	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 42	1	w042.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w042.raw	42	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 43	1	w043.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w043.raw	43	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 43	1	w043.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w043.raw	43	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 43	1	w043.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w043.raw	43	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 43	1	w043.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w043.raw	43	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 43	1	w043.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w043.raw	43	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 43	1	w043.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w043.raw	43	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 43	1	w043.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w043.raw	43	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 43	1	w043.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w043.raw	43	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 43	1	w043.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w043.raw	43	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 43	1	w043.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w043.raw	43	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 44	1	w044.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w044.raw	44	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 44	1	w044.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w044.raw	44	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 44	1	w044.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w044.raw	44	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 44	1	w044.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w044.raw	44	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 44	1	w044.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w044.raw	44	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 44	1	w044.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w044.raw	44	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 44	1	w044.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w044.raw	44	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 44	1	w044.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w044.raw	44	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 44	1	w044.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w044.raw	44	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 44	1	w044.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w044.raw	44	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 45	1	w045.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w045.raw	45	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 45	1	w045.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w045.raw	45	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 45	1	w045.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w045.raw	45	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 45	1	w045.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w045.raw	45	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 45	1	w045.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w045.raw	45	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 45	1	w045.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w045.raw	45	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 45	1	w045.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w045.raw	45	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 45	1	w045.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w045.raw	45	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 45	1	w045.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w045.raw	45	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 45	1	w045.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w045.raw	45	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 46	1	w046.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w046.raw	46	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 46	1	w046.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w046.raw	46	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 46	1	w046.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w046.raw	46	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 46	1	w046.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w046.raw	46	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 46	1	w046.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w046.raw	46	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 46	1	w046.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w046.raw	46	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 46	1	w046.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w046.raw	46	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 46	1	w046.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w046.raw	46	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 46	1	w046.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w046.raw	46	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 46	1	w046.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w046.raw	46	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 47	1	w047.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w047.raw	47	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 47	1	w047.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w047.raw	47	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 47	1	w047.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w047.raw	47	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 47	1	w047.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w047.raw	47	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 47	1	w047.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w047.raw	47	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 47	1	w047.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w047.raw	47	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 47	1	w047.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w047.raw	47	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 47	1	w047.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w047.raw	47	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 47	1	w047.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w047.raw	47	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 47	1	w047.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w047.raw	47	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 48	1	w048.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w048.raw	48	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 48	1	w048.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w048.raw	48	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 48	1	w048.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w048.raw	48	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 48	1	w048.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w048.raw	48	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 48	1	w048.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w048.raw	48	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 48	1	w048.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w048.raw	48	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 48	1	w048.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w048.raw	48	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 48	1	w048.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w048.raw	48	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 48	1	w048.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w048.raw	48	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 48	1	w048.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w048.raw	48	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 49	1	w049.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w049.raw	49	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 49	1	w049.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w049.raw	49	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 49	1	w049.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w049.raw	49	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 49	1	w049.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w049.raw	49	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 49	1	w049.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w049.raw	49	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 49	1	w049.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w049.raw	49	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 49	1	w049.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w049.raw	49	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 49	1	w049.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w049.raw	49	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 49	1	w049.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w049.raw	49	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 49	1	w049.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w049.raw	49	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 50	1	w050.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w050.raw	50	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 50	1	w050.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w050.raw	50	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 50	1	w050.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w050.raw	50	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 50	1	w050.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w050.raw	50	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 50	1	w050.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w050.raw	50	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 50	1	w050.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w050.raw	50	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 50	1	w050.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w050.raw	50	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 50	1	w050.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w050.raw	50	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 50	1	w050.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w050.raw	50	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 50	1	w050.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w050.raw	50	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 51	1	w051.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w051.raw	51	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 51	1	w051.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w051.raw	51	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 51	1	w051.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w051.raw	51	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 51	1	w051.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w051.raw	51	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 51	1	w051.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w051.raw	51	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 51	1	w051.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w051.raw	51	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 51	1	w051.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w051.raw	51	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 51	1	w051.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w051.raw	51	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 51	1	w051.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w051.raw	51	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 51	1	w051.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w051.raw	51	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 52	1	w052.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w052.raw	52	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 52	1	w052.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w052.raw	52	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 52	1	w052.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w052.raw	52	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 52	1	w052.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w052.raw	52	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 52	1	w052.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w052.raw	52	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 52	1	w052.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w052.raw	52	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 52	1	w052.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w052.raw	52	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 52	1	w052.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w052.raw	52	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 52	1	w052.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w052.raw	52	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 52	1	w052.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w052.raw	52	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 53	1	w053.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w053.raw	53	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 53	1	w053.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w053.raw	53	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 53	1	w053.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w053.raw	53	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 53	1	w053.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w053.raw	53	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 53	1	w053.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w053.raw	53	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 53	1	w053.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w053.raw	53	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 53	1	w053.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w053.raw	53	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 53	1	w053.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w053.raw	53	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 53	1	w053.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w053.raw	53	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 53	1	w053.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w053.raw	53	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 54	1	w054.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w054.raw	54	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 54	1	w054.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w054.raw	54	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 54	1	w054.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w054.raw	54	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 54	1	w054.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w054.raw	54	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 54	1	w054.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w054.raw	54	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 54	1	w054.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w054.raw	54	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 54	1	w054.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w054.raw	54	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 54	1	w054.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w054.raw	54	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 54	1	w054.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w054.raw	54	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 54	1	w054.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w054.raw	54	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 55	1	w055.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w055.raw	55	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 55	1	w055.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w055.raw	55	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 55	1	w055.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w055.raw	55	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 55	1	w055.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w055.raw	55	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 55	1	w055.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w055.raw	55	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 55	1	w055.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w055.raw	55	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 55	1	w055.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w055.raw	55	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 55	1	w055.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w055.raw	55	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 55	1	w055.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w055.raw	55	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 55	1	w055.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w055.raw	55	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 56	1	w056.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w056.raw	56	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 56	1	w056.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w056.raw	56	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 56	1	w056.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w056.raw	56	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 56	1	w056.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w056.raw	56	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 56	1	w056.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w056.raw	56	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 56	1	w056.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w056.raw	56	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 56	1	w056.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w056.raw	56	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 56	1	w056.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w056.raw	56	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 56	1	w056.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w056.raw	56	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 56	1	w056.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w056.raw	56	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 57	1	w057.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w057.raw	57	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 57	1	w057.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w057.raw	57	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 57	1	w057.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w057.raw	57	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 57	1	w057.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w057.raw	57	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 57	1	w057.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w057.raw	57	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 57	1	w057.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w057.raw	57	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 57	1	w057.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w057.raw	57	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 57	1	w057.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w057.raw	57	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 57	1	w057.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w057.raw	57	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 57	1	w057.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w057.raw	57	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 58	1	w058.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w058.raw	58	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 58	1	w058.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w058.raw	58	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 58	1	w058.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w058.raw	58	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 58	1	w058.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w058.raw	58	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 58	1	w058.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w058.raw	58	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 58	1	w058.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w058.raw	58	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 58	1	w058.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w058.raw	58	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 58	1	w058.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w058.raw	58	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 58	1	w058.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w058.raw	58	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 58	1	w058.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w058.raw	58	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 59	1	w059.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w059.raw	59	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 59	1	w059.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w059.raw	59	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 59	1	w059.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w059.raw	59	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 59	1	w059.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w059.raw	59	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 59	1	w059.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w059.raw	59	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 59	1	w059.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w059.raw	59	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 59	1	w059.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w059.raw	59	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 59	1	w059.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w059.raw	59	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 59	1	w059.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w059.raw	59	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 59	1	w059.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w059.raw	59	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 60	1	w060.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w060.raw	60	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 60	1	w060.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w060.raw	60	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 60	1	w060.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w060.raw	60	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 60	1	w060.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w060.raw	60	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 60	1	w060.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w060.raw	60	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 60	1	w060.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w060.raw	60	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 60	1	w060.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w060.raw	60	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 60	1	w060.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w060.raw	60	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 60	1	w060.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w060.raw	60	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 60	1	w060.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w060.raw	60	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 61	1	w061.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w061.raw	61	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 61	1	w061.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w061.raw	61	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 61	1	w061.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w061.raw	61	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 61	1	w061.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w061.raw	61	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 61	1	w061.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w061.raw	61	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 61	1	w061.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w061.raw	61	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 61	1	w061.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w061.raw	61	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 61	1	w061.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w061.raw	61	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 61	1	w061.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w061.raw	61	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 61	1	w061.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w061.raw	61	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 62	1	w062.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w062.raw	62	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 62	1	w062.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w062.raw	62	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 62	1	w062.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w062.raw	62	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 62	1	w062.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w062.raw	62	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 62	1	w062.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w062.raw	62	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 62	1	w062.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w062.raw	62	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 62	1	w062.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w062.raw	62	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 62	1	w062.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w062.raw	62	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 62	1	w062.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w062.raw	62	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 62	1	w062.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w062.raw	62	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 63	1	w063.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w063.raw	63	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 63	1	w063.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w063.raw	63	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 63	1	w063.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w063.raw	63	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 63	1	w063.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w063.raw	63	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 63	1	w063.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w063.raw	63	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 63	1	w063.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w063.raw	63	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 63	1	w063.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w063.raw	63	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 63	1	w063.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w063.raw	63	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 63	1	w063.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w063.raw	63	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 63	1	w063.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w063.raw	63	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 64	1	w064.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w064.raw	64	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 64	1	w064.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w064.raw	64	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 64	1	w064.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w064.raw	64	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 64	1	w064.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w064.raw	64	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 64	1	w064.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w064.raw	64	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 64	1	w064.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w064.raw	64	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 64	1	w064.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w064.raw	64	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 64	1	w064.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w064.raw	64	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 64	1	w064.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w064.raw	64	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 64	1	w064.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w064.raw	64	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 65	1	w065.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w065.raw	65	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 65	1	w065.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w065.raw	65	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 65	1	w065.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w065.raw	65	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 65	1	w065.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w065.raw	65	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 65	1	w065.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w065.raw	65	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 65	1	w065.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w065.raw	65	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 65	1	w065.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w065.raw	65	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 65	1	w065.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w065.raw	65	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 65	1	w065.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w065.raw	65	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 65	1	w065.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w065.raw	65	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 66	1	w066.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w066.raw	66	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 66	1	w066.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w066.raw	66	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 66	1	w066.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w066.raw	66	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 66	1	w066.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w066.raw	66	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 66	1	w066.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w066.raw	66	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 66	1	w066.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w066.raw	66	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 66	1	w066.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w066.raw	66	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 66	1	w066.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w066.raw	66	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 66	1	w066.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w066.raw	66	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 66	1	w066.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w066.raw	66	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 67	1	w067.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w067.raw	67	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 67	1	w067.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w067.raw	67	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 67	1	w067.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w067.raw	67	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 67	1	w067.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w067.raw	67	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 67	1	w067.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w067.raw	67	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 67	1	w067.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w067.raw	67	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 67	1	w067.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w067.raw	67	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 67	1	w067.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w067.raw	67	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 67	1	w067.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w067.raw	67	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 67	1	w067.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w067.raw	67	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 68	1	w068.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w068.raw	68	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 68	1	w068.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w068.raw	68	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 68	1	w068.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w068.raw	68	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 68	1	w068.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w068.raw	68	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 68	1	w068.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w068.raw	68	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 68	1	w068.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w068.raw	68	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 68	1	w068.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w068.raw	68	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 68	1	w068.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w068.raw	68	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 68	1	w068.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w068.raw	68	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 68	1	w068.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w068.raw	68	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 69	1	w069.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w069.raw	69	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 69	1	w069.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w069.raw	69	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 69	1	w069.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w069.raw	69	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 69	1	w069.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w069.raw	69	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 69	1	w069.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w069.raw	69	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 69	1	w069.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w069.raw	69	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 69	1	w069.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w069.raw	69	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 69	1	w069.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w069.raw	69	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 69	1	w069.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w069.raw	69	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 69	1	w069.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w069.raw	69	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 70	1	w070.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w070.raw	70	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 70	1	w070.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w070.raw	70	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 70	1	w070.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w070.raw	70	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 70	1	w070.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w070.raw	70	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 70	1	w070.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w070.raw	70	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 70	1	w070.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w070.raw	70	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 70	1	w070.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w070.raw	70	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 70	1	w070.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w070.raw	70	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 70	1	w070.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w070.raw	70	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 70	1	w070.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w070.raw	70	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 71	1	w071.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w071.raw	71	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 71	1	w071.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w071.raw	71	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 71	1	w071.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w071.raw	71	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 71	1	w071.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w071.raw	71	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 71	1	w071.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w071.raw	71	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 71	1	w071.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w071.raw	71	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 71	1	w071.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w071.raw	71	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 71	1	w071.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w071.raw	71	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 71	1	w071.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w071.raw	71	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 71	1	w071.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w071.raw	71	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 72	1	w072.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w072.raw	72	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 72	1	w072.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w072.raw	72	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 72	1	w072.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w072.raw	72	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 72	1	w072.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w072.raw	72	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 72	1	w072.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w072.raw	72	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 72	1	w072.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w072.raw	72	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 72	1	w072.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w072.raw	72	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 72	1	w072.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w072.raw	72	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 72	1	w072.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w072.raw	72	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 72	1	w072.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w072.raw	72	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 73	1	w073.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w073.raw	73	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 73	1	w073.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w073.raw	73	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 73	1	w073.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w073.raw	73	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 73	1	w073.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w073.raw	73	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 73	1	w073.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w073.raw	73	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 73	1	w073.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w073.raw	73	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 73	1	w073.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w073.raw	73	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 73	1	w073.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w073.raw	73	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 73	1	w073.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w073.raw	73	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 73	1	w073.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w073.raw	73	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 74	1	w074.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w074.raw	74	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 74	1	w074.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w074.raw	74	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 74	1	w074.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w074.raw	74	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 74	1	w074.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w074.raw	74	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 74	1	w074.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w074.raw	74	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 74	1	w074.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w074.raw	74	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 74	1	w074.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w074.raw	74	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 74	1	w074.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w074.raw	74	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 74	1	w074.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w074.raw	74	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 74	1	w074.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w074.raw	74	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 75	1	w075.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w075.raw	75	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 75	1	w075.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w075.raw	75	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 75	1	w075.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w075.raw	75	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 75	1	w075.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w075.raw	75	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 75	1	w075.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w075.raw	75	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 75	1	w075.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w075.raw	75	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 75	1	w075.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w075.raw	75	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 75	1	w075.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w075.raw	75	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 75	1	w075.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w075.raw	75	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 75	1	w075.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w075.raw	75	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 76	1	w076.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w076.raw	76	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 76	1	w076.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w076.raw	76	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 76	1	w076.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w076.raw	76	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 76	1	w076.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w076.raw	76	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 76	1	w076.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w076.raw	76	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 76	1	w076.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w076.raw	76	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 76	1	w076.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w076.raw	76	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 76	1	w076.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w076.raw	76	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 76	1	w076.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w076.raw	76	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 76	1	w076.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w076.raw	76	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 77	1	w077.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w077.raw	77	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 77	1	w077.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w077.raw	77	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 77	1	w077.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w077.raw	77	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 77	1	w077.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w077.raw	77	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 77	1	w077.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w077.raw	77	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 77	1	w077.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w077.raw	77	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 77	1	w077.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w077.raw	77	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 77	1	w077.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w077.raw	77	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 77	1	w077.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w077.raw	77	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 77	1	w077.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w077.raw	77	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 78	1	w078.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w078.raw	78	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 78	1	w078.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w078.raw	78	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 78	1	w078.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w078.raw	78	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 78	1	w078.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w078.raw	78	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 78	1	w078.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w078.raw	78	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 78	1	w078.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w078.raw	78	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 78	1	w078.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w078.raw	78	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 78	1	w078.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w078.raw	78	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 78	1	w078.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w078.raw	78	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 78	1	w078.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w078.raw	78	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 79	1	w079.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w079.raw	79	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 79	1	w079.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w079.raw	79	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 79	1	w079.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w079.raw	79	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 79	1	w079.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w079.raw	79	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 79	1	w079.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w079.raw	79	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 79	1	w079.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w079.raw	79	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 79	1	w079.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w079.raw	79	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 79	1	w079.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w079.raw	79	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 79	1	w079.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w079.raw	79	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 79	1	w079.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w079.raw	79	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 80	1	w080.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w080.raw	80	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 80	1	w080.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w080.raw	80	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 80	1	w080.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w080.raw	80	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 80	1	w080.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w080.raw	80	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 80	1	w080.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w080.raw	80	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 80	1	w080.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w080.raw	80	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 80	1	w080.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w080.raw	80	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 80	1	w080.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w080.raw	80	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 80	1	w080.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w080.raw	80	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 80	1	w080.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w080.raw	80	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 81	1	w081.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w081.raw	81	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 81	1	w081.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w081.raw	81	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 81	1	w081.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w081.raw	81	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 81	1	w081.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w081.raw	81	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 81	1	w081.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w081.raw	81	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 81	1	w081.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w081.raw	81	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 81	1	w081.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w081.raw	81	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 81	1	w081.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w081.raw	81	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 81	1	w081.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w081.raw	81	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 81	1	w081.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w081.raw	81	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 82	1	w082.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w082.raw	82	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 82	1	w082.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w082.raw	82	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 82	1	w082.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w082.raw	82	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 82	1	w082.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w082.raw	82	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 82	1	w082.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w082.raw	82	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 82	1	w082.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w082.raw	82	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 82	1	w082.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w082.raw	82	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 82	1	w082.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w082.raw	82	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 82	1	w082.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w082.raw	82	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 82	1	w082.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w082.raw	82	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 83	1	w083.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w083.raw	83	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 83	1	w083.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w083.raw	83	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 83	1	w083.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w083.raw	83	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 83	1	w083.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w083.raw	83	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 83	1	w083.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w083.raw	83	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 83	1	w083.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w083.raw	83	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 83	1	w083.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w083.raw	83	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 83	1	w083.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w083.raw	83	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 83	1	w083.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w083.raw	83	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 83	1	w083.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w083.raw	83	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 84	1	w084.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w084.raw	84	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 84	1	w084.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w084.raw	84	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 84	1	w084.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w084.raw	84	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 84	1	w084.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w084.raw	84	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 84	1	w084.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w084.raw	84	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 84	1	w084.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w084.raw	84	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 84	1	w084.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w084.raw	84	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 84	1	w084.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w084.raw	84	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 84	1	w084.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w084.raw	84	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 84	1	w084.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w084.raw	84	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 85	1	w085.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w085.raw	85	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 85	1	w085.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w085.raw	85	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 85	1	w085.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w085.raw	85	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 85	1	w085.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w085.raw	85	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 85	1	w085.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w085.raw	85	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 85	1	w085.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w085.raw	85	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 85	1	w085.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w085.raw	85	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 85	1	w085.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w085.raw	85	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 85	1	w085.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w085.raw	85	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 85	1	w085.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w085.raw	85	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 86	1	w086.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w086.raw	86	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 86	1	w086.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w086.raw	86	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 86	1	w086.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w086.raw	86	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 86	1	w086.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w086.raw	86	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 86	1	w086.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w086.raw	86	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 86	1	w086.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w086.raw	86	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 86	1	w086.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w086.raw	86	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 86	1	w086.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w086.raw	86	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 86	1	w086.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w086.raw	86	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 86	1	w086.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w086.raw	86	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 87	1	w087.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w087.raw	87	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 87	1	w087.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w087.raw	87	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 87	1	w087.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w087.raw	87	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 87	1	w087.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w087.raw	87	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 87	1	w087.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w087.raw	87	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 87	1	w087.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w087.raw	87	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 87	1	w087.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w087.raw	87	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 87	1	w087.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w087.raw	87	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 87	1	w087.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w087.raw	87	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 87	1	w087.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w087.raw	87	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 88	1	w088.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w088.raw	88	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 88	1	w088.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w088.raw	88	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 88	1	w088.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w088.raw	88	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 88	1	w088.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w088.raw	88	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 88	1	w088.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w088.raw	88	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 88	1	w088.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w088.raw	88	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 88	1	w088.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w088.raw	88	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 88	1	w088.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w088.raw	88	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 88	1	w088.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w088.raw	88	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 88	1	w088.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w088.raw	88	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 89	1	w089.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w089.raw	89	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 89	1	w089.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w089.raw	89	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 89	1	w089.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w089.raw	89	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 89	1	w089.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w089.raw	89	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 89	1	w089.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w089.raw	89	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 89	1	w089.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w089.raw	89	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 89	1	w089.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w089.raw	89	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 89	1	w089.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w089.raw	89	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 89	1	w089.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w089.raw	89	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 89	1	w089.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w089.raw	89	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 90	1	w090.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w090.raw	90	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 90	1	w090.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w090.raw	90	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 90	1	w090.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w090.raw	90	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 90	1	w090.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w090.raw	90	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 90	1	w090.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w090.raw	90	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 90	1	w090.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w090.raw	90	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 90	1	w090.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w090.raw	90	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 90	1	w090.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w090.raw	90	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 90	1	w090.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w090.raw	90	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 90	1	w090.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w090.raw	90	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 91	1	w091.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w091.raw	91	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 91	1	w091.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w091.raw	91	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 91	1	w091.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w091.raw	91	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 91	1	w091.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w091.raw	91	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 91	1	w091.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w091.raw	91	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 91	1	w091.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w091.raw	91	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 91	1	w091.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w091.raw	91	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 91	1	w091.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w091.raw	91	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 91	1	w091.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w091.raw	91	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 91	1	w091.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w091.raw	91	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 92	1	w092.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w092.raw	92	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 92	1	w092.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w092.raw	92	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 92	1	w092.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w092.raw	92	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 92	1	w092.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w092.raw	92	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 92	1	w092.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w092.raw	92	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 92	1	w092.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w092.raw	92	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 92	1	w092.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w092.raw	92	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 92	1	w092.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w092.raw	92	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 92	1	w092.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w092.raw	92	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 92	1	w092.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w092.raw	92	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 93	1	w093.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w093.raw	93	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 93	1	w093.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w093.raw	93	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 93	1	w093.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w093.raw	93	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 93	1	w093.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w093.raw	93	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 93	1	w093.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w093.raw	93	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 93	1	w093.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w093.raw	93	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 93	1	w093.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w093.raw	93	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 93	1	w093.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w093.raw	93	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 93	1	w093.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w093.raw	93	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 93	1	w093.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w093.raw	93	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 94	1	w094.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w094.raw	94	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 94	1	w094.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w094.raw	94	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 94	1	w094.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w094.raw	94	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 94	1	w094.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w094.raw	94	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 94	1	w094.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w094.raw	94	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 94	1	w094.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w094.raw	94	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 94	1	w094.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w094.raw	94	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 94	1	w094.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w094.raw	94	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 94	1	w094.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w094.raw	94	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 94	1	w094.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w094.raw	94	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 95	1	w095.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w095.raw	95	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 95	1	w095.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w095.raw	95	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 95	1	w095.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w095.raw	95	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 95	1	w095.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w095.raw	95	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 95	1	w095.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w095.raw	95	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 95	1	w095.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w095.raw	95	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 95	1	w095.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w095.raw	95	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 95	1	w095.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w095.raw	95	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 95	1	w095.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w095.raw	95	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 95	1	w095.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w095.raw	95	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 96	1	w096.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w096.raw	96	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 96	1	w096.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w096.raw	96	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 96	1	w096.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w096.raw	96	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 96	1	w096.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w096.raw	96	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 96	1	w096.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w096.raw	96	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 96	1	w096.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w096.raw	96	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 96	1	w096.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w096.raw	96	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 96	1	w096.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w096.raw	96	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 96	1	w096.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w096.raw	96	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 96	1	w096.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w096.raw	96	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 97	1	w097.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w097.raw	97	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 97	1	w097.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w097.raw	97	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 97	1	w097.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w097.raw	97	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 97	1	w097.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w097.raw	97	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 97	1	w097.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w097.raw	97	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 97	1	w097.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w097.raw	97	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 97	1	w097.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w097.raw	97	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 97	1	w097.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w097.raw	97	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 97	1	w097.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w097.raw	97	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 97	1	w097.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w097.raw	97	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 98	1	w098.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w098.raw	98	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 98	1	w098.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w098.raw	98	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 98	1	w098.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w098.raw	98	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 98	1	w098.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w098.raw	98	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 98	1	w098.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w098.raw	98	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 98	1	w098.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w098.raw	98	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 98	1	w098.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w098.raw	98	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 98	1	w098.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w098.raw	98	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 98	1	w098.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w098.raw	98	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 98	1	w098.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w098.raw	98	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 99	1	w099.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w099.raw	99	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 99	1	w099.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w099.raw	99	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 99	1	w099.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w099.raw	99	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 99	1	w099.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w099.raw	99	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 99	1	w099.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w099.raw	99	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 99	1	w099.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w099.raw	99	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 99	1	w099.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w099.raw	99	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 99	1	w099.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w099.raw	99	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 99	1	w099.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w099.raw	99	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 99	1	w099.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w099.raw	99	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 100	1	w100.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w100.raw	100	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 100	1	w100.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w100.raw	100	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 100	1	w100.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w100.raw	100	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 100	1	w100.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w100.raw	100	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 100	1	w100.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w100.raw	100	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 100	1	w100.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w100.raw	100	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 100	1	w100.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w100.raw	100	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 100	1	w100.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w100.raw	100	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 100	1	w100.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w100.raw	100	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 100	1	w100.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w100.raw	100	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 101	1	w101.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w101.raw	101	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 101	1	w101.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w101.raw	101	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 101	1	w101.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w101.raw	101	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 101	1	w101.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w101.raw	101	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 101	1	w101.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w101.raw	101	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 101	1	w101.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w101.raw	101	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 101	1	w101.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w101.raw	101	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 101	1	w101.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w101.raw	101	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 101	1	w101.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w101.raw	101	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 101	1	w101.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w101.raw	101	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 102	1	w102.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w102.raw	102	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 102	1	w102.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w102.raw	102	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 102	1	w102.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w102.raw	102	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 102	1	w102.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w102.raw	102	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 102	1	w102.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w102.raw	102	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 102	1	w102.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w102.raw	102	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 102	1	w102.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w102.raw	102	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 102	1	w102.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w102.raw	102	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 102	1	w102.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w102.raw	102	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 102	1	w102.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w102.raw	102	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 103	1	w103.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w103.raw	103	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 103	1	w103.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w103.raw	103	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 103	1	w103.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w103.raw	103	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 103	1	w103.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w103.raw	103	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 103	1	w103.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w103.raw	103	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 103	1	w103.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w103.raw	103	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 103	1	w103.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w103.raw	103	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 103	1	w103.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w103.raw	103	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 103	1	w103.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w103.raw	103	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 103	1	w103.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w103.raw	103	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 104	1	w104.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w104.raw	104	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 104	1	w104.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w104.raw	104	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 104	1	w104.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w104.raw	104	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 104	1	w104.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w104.raw	104	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 104	1	w104.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w104.raw	104	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 104	1	w104.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w104.raw	104	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 104	1	w104.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w104.raw	104	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 104	1	w104.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w104.raw	104	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 104	1	w104.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w104.raw	104	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 104	1	w104.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w104.raw	104	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 1	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 105	1	w105.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w105.raw	105	TMT126	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 2	homo sapiens	brain	not available	not available	not available	not available	controls with a low pathology of plaques and tangles (LPCs)	1	tissue	proteomic profiling by mass spectrometry	run 105	1	w105.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w105.raw	105	TMT127N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with a low pathology of plaques and tangles (LPCs)
Sample 3	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 105	1	w105.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w105.raw	105	TMT127C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 4	homo sapiens	brain	not available	not available	not available	not available	controls with high A¦Â pathology but no detectable cognitive defects	1	tissue	proteomic profiling by mass spectrometry	run 105	1	w105.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w105.raw	105	TMT128N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	controls with high A¦Â pathology but no detectable cognitive defects
Sample 5	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 105	1	w105.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w105.raw	105	TMT128C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 6	homo sapiens	brain	not available	not available	not available	not available	mild cognitive impairment (MCI)	1	tissue	proteomic profiling by mass spectrometry	run 105	1	w105.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w105.raw	105	TMT129N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	mild cognitive impairment (MCI)
Sample 7	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 105	1	w105.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w105.raw	105	TMT129C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 8	homo sapiens	brain	not available	not available	not available	not available	late-stage AD with high pathology scores of plaques and tangles (AD)	1	tissue	proteomic profiling by mass spectrometry	run 105	1	w105.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w105.raw	105	TMT130N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	late-stage AD with high pathology scores of plaques and tangles (AD)
Sample 9	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 105	1	w105.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w105.raw	105	TMT130C	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
Sample 10	homo sapiens	brain	not available	not available	not available	not available	progressive supranuclear palsy (PSP)	1	tissue	proteomic profiling by mass spectrometry	run 105	1	w105.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/w105.raw	105	TMT131N	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Trypsin;AC=MS:1001251	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=HCD;AC=PRIDE:0000590	35%-38% NCE	8 ppm	15 ppm	progressive supranuclear palsy (PSP)
